Jeff Hergenrader

Senior Director Business Development at EmVenio Research

Jeff Hergenrader has over 18 years of experience in business development and sales roles in the healthcare and clinical trials industry. Their most recent role was with EmVenio Research as the Senior Director of Business Development, starting in September 2022. Prior to that, they worked at THREAD as the Senior Director of Business Development from April 2022 to September 2022. From February 2021 to January 2022, Jeff held the position of Senior Vice President of Business Development at Xperiome, a global healthtech company specializing in rare disease patient insights. Before that, they served as the Director of Partner Account Management at Medidata Solutions from May 2019 to January 2021. Jeff also held senior director positions at ERT, where they were responsible for portfolio business development from September 2018 to April 2019, and at Exco InTouch (acquired by ERT), where they served as the Director of Business Development from April 2015 to January 2017. Jeff started their career at CellzDirect as the Senior Regional Sales Manager from December 2004 to February 2008, selling hepatocytes and other products used in preclinical research. Jeff's experience also includes roles at DATATRAK International, Aptiv Solutions, and DP Clinical Inc. Overall, Jeff Hergenrader has a strong background in business development within the healthcare and clinical trials industry, with a particular focus on rare disease and patient engagement.

Jeff Hergenrader earned a Bachelor's Degree in Business Administration and Management from NC Wesleyan from 2001 to 2003. Prior to that, they attended North Carolina State University from 1989 to 1992, although the specific degree and field of study are unknown. Additionally, there is mention of him attending EA Laney, but no details about the years or any degrees earned from that institution.

Links

Previous companies

Medidata Solutions logo
Xperiome logo

Timeline

  • Senior Director Business Development

    September, 2022 - present